A comparison of rh-TSH and thyroid hormone withdrawal in patients with differentiated thyroid cancer: preliminary evidence for an influence of age on the subjective well-being in hypothyroidism

Horm Metab Res. 2012 Jan;44(1):54-9. doi: 10.1055/s-0031-1295415. Epub 2011 Nov 22.

Abstract

We aimed to investigate the subjective well-being in patients with differentiated thyroid cancer after hormone withdrawal. Since this might be confounded by psycho-oncological processes unrelated to hypothyroidism we intended to minimize such factors by only including patients with a history of uneventful follow-up examinations for several years. We investigated 67 patients applying the General Health Questionnaire (GHQ-12) at 3 time points t1, t2, and t3. The time point t2 represented an intensified follow-up examination 5 years after thyroidectomy, which was performed either on hormone withdrawal (49 patients) or using rh-TSH (18 patients). The time points t1 and t3 took place during follow-up examinations 6 months before and after t2 in a euthyroid state. Additionally, we assessed the impact of age, gender, family status, and education on the GHQ-12 score at all 3 time points. Within the hormone withdrawal group the analyses demonstrated a significant difference between t1 and t2 as well as t3 and t2. Additionally, there was a significant negative correlation of age with GHQ-12 sum scores at t2, but not at t1 or t3. Subgroup analyses at t2 indicated that the subjective well-being in younger patients was more impaired compared to elderly patients. The between-group analysis showed no significant differences. However, concerning the age effect there was a significant difference between the subgroup of young hypothyroid patients and the total rh-TSH group at t2. We demonstrated preliminary evidence for an influence of age on the subjective well-being in hypothyroidism suggesting that younger subjects are subjectively more impaired by hypothyroidism than elderly ones.

Publication types

  • Comparative Study

MeSH terms

  • Aging / pathology*
  • Cell Differentiation / drug effects
  • Female
  • Humans
  • Hypothyroidism / complications*
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use*
  • Statistics, Nonparametric
  • Surveys and Questionnaires
  • Thyroid Hormones / pharmacology
  • Thyroid Hormones / therapeutic use*
  • Thyroid Neoplasms / complications
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / pathology*
  • Thyrotropin / therapeutic use*
  • Time Factors

Substances

  • Recombinant Proteins
  • Thyroid Hormones
  • Thyrotropin